RxDoctor Payments Data

Lee Simon

Rheumatology · Boston, MANPI 1457494932

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $575,902 of the $600,301 with a category attached, or 95.9%. 17 manufacturers reported payments, led by Amgen at 56.7% of the total. Reporting peaked in 2019 at $236,600 and has fallen 91.7% since, to $19,532 in 2025. Among rheumatology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$600,301in general payments, 2019–2025

Across 163 payments — averaging $3682.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$341K
  • Pfizer$61K
  • Boehringer Ingelheim International GmbH$57K
  • Teikoku Pharma USA, Inc.$26K
  • Eli Lilly$21K
  • Lilly USA, LLC$19K
  • plus $77K from 11 others

What the payments were for

  • Consulting fees$575,90296%
  • Speaking & faculty fees$16,3343%
  • Travel & lodging$7,4871%
  • Food & beverage$5770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$600,301 in reported general payments places this provider in the 95th percentile of 265 rheumatology providers in Massachusetts.

See all rheumatology providers in Massachusetts

Other rheumatology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →